1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Therapeutics 1.2.3 Vaccine 1.3 Market by Application 1.3.1 Global Hepatitis C Virus (HCV) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Diagnostic Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hepatitis C Virus (HCV) Market Perspective (2016-2027) 2.2 Hepatitis C Virus (HCV) Growth Trends by Regions 2.2.1 Hepatitis C Virus (HCV) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hepatitis C Virus (HCV) Historic Market Share by Regions (2016-2021) 2.2.3 Hepatitis C Virus (HCV) Forecasted Market Size by Regions (2022-2027) 2.3 Hepatitis C Virus (HCV) Industry Dynamic 2.3.1 Hepatitis C Virus (HCV) Market Trends 2.3.2 Hepatitis C Virus (HCV) Market Drivers 2.3.3 Hepatitis C Virus (HCV) Market Challenges 2.3.4 Hepatitis C Virus (HCV) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hepatitis C Virus (HCV) Players by Revenue 3.1.1 Global Top Hepatitis C Virus (HCV) Players by Revenue (2016-2021) 3.1.2 Global Hepatitis C Virus (HCV) Revenue Market Share by Players (2016-2021) 3.2 Global Hepatitis C Virus (HCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Revenue 3.4 Global Hepatitis C Virus (HCV) Market Concentration Ratio 3.4.1 Global Hepatitis C Virus (HCV) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Revenue in 2020 3.5 Hepatitis C Virus (HCV) Key Players Head office and Area Served 3.6 Key Players Hepatitis C Virus (HCV) Product Solution and Service 3.7 Date of Enter into Hepatitis C Virus (HCV) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hepatitis C Virus (HCV) Breakdown Data by Type 4.1 Global Hepatitis C Virus (HCV) Historic Market Size by Type (2016-2021) 4.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2022-2027) 5 Hepatitis C Virus (HCV) Breakdown Data by Application 5.1 Global Hepatitis C Virus (HCV) Historic Market Size by Application (2016-2021) 5.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hepatitis C Virus (HCV) Market Size (2016-2027) 6.2 North America Hepatitis C Virus (HCV) Market Size by Type 6.2.1 North America Hepatitis C Virus (HCV) Market Size by Type (2016-2021) 6.2.2 North America Hepatitis C Virus (HCV) Market Size by Type (2022-2027) 6.2.3 North America Hepatitis C Virus (HCV) Market Size by Type (2016-2027) 6.3 North America Hepatitis C Virus (HCV) Market Size by Application 6.3.1 North America Hepatitis C Virus (HCV) Market Size by Application (2016-2021) 6.3.2 North America Hepatitis C Virus (HCV) Market Size by Application (2022-2027) 6.3.3 North America Hepatitis C Virus (HCV) Market Size by Application (2016-2027) 6.4 North America Hepatitis C Virus (HCV) Market Size by Country 6.4.1 North America Hepatitis C Virus (HCV) Market Size by Country (2016-2021) 6.4.2 North America Hepatitis C Virus (HCV) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Hepatitis C Virus (HCV) Market Size (2016-2027) 7.2 Europe Hepatitis C Virus (HCV) Market Size by Type 7.2.1 Europe Hepatitis C Virus (HCV) Market Size by Type (2016-2021) 7.2.2 Europe Hepatitis C Virus (HCV) Market Size by Type (2022-2027) 7.2.3 Europe Hepatitis C Virus (HCV) Market Size by Type (2016-2027) 7.3 Europe Hepatitis C Virus (HCV) Market Size by Application 7.3.1 Europe Hepatitis C Virus (HCV) Market Size by Application (2016-2021) 7.3.2 Europe Hepatitis C Virus (HCV) Market Size by Application (2022-2027) 7.3.3 Europe Hepatitis C Virus (HCV) Market Size by Application (2016-2027) 7.4 Europe Hepatitis C Virus (HCV) Market Size by Country 7.4.1 Europe Hepatitis C Virus (HCV) Market Size by Country (2016-2021) 7.4.2 Europe Hepatitis C Virus (HCV) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size (2016-2027) 8.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type 8.2.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2016-2027) 8.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application 8.3.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2016-2027) 8.4 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region 8.4.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hepatitis C Virus (HCV) Market Size (2016-2027) 9.2 Latin America Hepatitis C Virus (HCV) Market Size by Type 9.2.1 Latin America Hepatitis C Virus (HCV) Market Size by Type (2016-2021) 9.2.2 Latin America Hepatitis C Virus (HCV) Market Size by Type (2022-2027) 9.2.3 Latin America Hepatitis C Virus (HCV) Market Size by Type (2016-2027) 9.3 Latin America Hepatitis C Virus (HCV) Market Size by Application 9.3.1 Latin America Hepatitis C Virus (HCV) Market Size by Application (2016-2021) 9.3.2 Latin America Hepatitis C Virus (HCV) Market Size by Application (2022-2027) 9.3.3 Latin America Hepatitis C Virus (HCV) Market Size by Application (2016-2027) 9.4 Latin America Hepatitis C Virus (HCV) Market Size by Country 9.4.1 Latin America Hepatitis C Virus (HCV) Market Size by Country (2016-2021) 9.4.2 Latin America Hepatitis C Virus (HCV) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size (2016-2027) 10.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type 10.2.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2016-2027) 10.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application 10.3.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2016-2027) 10.4 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country 10.4.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Hepatitis C Virus (HCV) Introduction 11.1.4 Merck Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.1.5 Merck Recent Development 11.2 Genentech 11.2.1 Genentech Company Details 11.2.2 Genentech Business Overview 11.2.3 Genentech Hepatitis C Virus (HCV) Introduction 11.2.4 Genentech Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.2.5 Genentech Recent Development 11.3 Vertex 11.3.1 Vertex Company Details 11.3.2 Vertex Business Overview 11.3.3 Vertex Hepatitis C Virus (HCV) Introduction 11.3.4 Vertex Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.3.5 Vertex Recent Development 11.4 Janssen and Medivir 11.4.1 Janssen and Medivir Company Details 11.4.2 Janssen and Medivir Business Overview 11.4.3 Janssen and Medivir Hepatitis C Virus (HCV) Introduction 11.4.4 Janssen and Medivir Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.4.5 Janssen and Medivir Recent Development 11.5 F. Hoffmann-La Roche 11.5.1 F. Hoffmann-La Roche Company Details 11.5.2 F. Hoffmann-La Roche Business Overview 11.5.3 F. Hoffmann-La Roche Hepatitis C Virus (HCV) Introduction 11.5.4 F. Hoffmann-La Roche Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.5.5 F. Hoffmann-La Roche Recent Development 11.6 Bristol Myers Squibb 11.6.1 Bristol Myers Squibb Company Details 11.6.2 Bristol Myers Squibb Business Overview 11.6.3 Bristol Myers Squibb Hepatitis C Virus (HCV) Introduction 11.6.4 Bristol Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.6.5 Bristol Myers Squibb Recent Development 11.7 AbbVie 11.7.1 AbbVie Company Details 11.7.2 AbbVie Business Overview 11.7.3 AbbVie Hepatitis C Virus (HCV) Introduction 11.7.4 AbbVie Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.7.5 AbbVie Recent Development 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Details 11.8.2 Gilead Sciences Business Overview 11.8.3 Gilead Sciences Hepatitis C Virus (HCV) Introduction 11.8.4 Gilead Sciences Revenue in Hepatitis C Virus (HCV) Business (2016-2021) 11.8.5 Gilead Sciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Therapeutics Table 3. Key Players of Vaccine Table 4. Global Hepatitis C Virus (HCV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Hepatitis C Virus (HCV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Hepatitis C Virus (HCV) Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Hepatitis C Virus (HCV) Market Share by Regions (2016-2021) Table 8. Global Hepatitis C Virus (HCV) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Hepatitis C Virus (HCV) Market Share by Regions (2022-2027) Table 10. Hepatitis C Virus (HCV) Market Trends Table 11. Hepatitis C Virus (HCV) Market Drivers Table 12. Hepatitis C Virus (HCV) Market Challenges Table 13. Hepatitis C Virus (HCV) Market Restraints Table 14. Global Hepatitis C Virus (HCV) Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Hepatitis C Virus (HCV) Market Share by Players (2016-2021) Table 16. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) as of 2020) Table 17. Ranking of Global Top Hepatitis C Virus (HCV) Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hepatitis C Virus (HCV) Product Solution and Service Table 21. Date of Enter into Hepatitis C Virus (HCV) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million) Table 24. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2016-2021) Table 25. Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Hepatitis C Virus (HCV) Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Hepatitis C Virus (HCV) Revenue Market Share by Application (2016-2021) Table 29. Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Hepatitis C Virus (HCV) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million) Table 32. North America Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million) Table 34. North America Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2022-2027) & (US$ Million) Table 61. Merck Company Details Table 62. Merck Business Overview Table 63. Merck Hepatitis C Virus (HCV) Product Table 64. Merck Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 65. Merck Recent Development Table 66. Genentech Company Details Table 67. Genentech Business Overview Table 68. Genentech Hepatitis C Virus (HCV) Product Table 69. Genentech Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 70. Genentech Recent Development Table 71. Vertex Company Details Table 72. Vertex Business Overview Table 73. Vertex Hepatitis C Virus (HCV) Product Table 74. Vertex Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 75. Vertex Recent Development Table 76. Janssen and Medivir Company Details Table 77. Janssen and Medivir Business Overview Table 78. Janssen and Medivir Hepatitis C Virus (HCV) Product Table 79. Janssen and Medivir Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 80. Janssen and Medivir Recent Development Table 81. F. Hoffmann-La Roche Company Details Table 82. F. Hoffmann-La Roche Business Overview Table 83. F. Hoffmann-La Roche Hepatitis C Virus (HCV) Product Table 84. F. Hoffmann-La Roche Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 85. F. Hoffmann-La Roche Recent Development Table 86. Bristol Myers Squibb Company Details Table 87. Bristol Myers Squibb Business Overview Table 88. Bristol Myers Squibb Hepatitis C Virus (HCV) Product Table 89. Bristol Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 90. Bristol Myers Squibb Recent Development Table 91. AbbVie Company Details Table 92. AbbVie Business Overview Table 93. AbbVie Hepatitis C Virus (HCV) Product Table 94. AbbVie Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 95. AbbVie Recent Development Table 96. Gilead Sciences Company Details Table 97. Gilead Sciences Business Overview Table 98. Gilead Sciences Revenue in Hepatitis C Virus (HCV) Business (2016-2021) & (US$ Million) Table 99. Gilead Sciences Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Hepatitis C Virus (HCV) Market Share by Type: 2020 VS 2027 Figure 2. Therapeutics Features Figure 3. Vaccine Features Figure 4. Global Hepatitis C Virus (HCV) Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Ambulatory Surgical Centers Case Studies Figure 7. Diagnostic Centers Case Studies Figure 8. Hepatitis C Virus (HCV) Report Years Considered Figure 9. Global Hepatitis C Virus (HCV) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Hepatitis C Virus (HCV) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Hepatitis C Virus (HCV) Market Share by Regions: 2020 VS 2027 Figure 12. Global Hepatitis C Virus (HCV) Market Share by Regions (2022-2027) Figure 13. Global Hepatitis C Virus (HCV) Market Share by Players in 2020 Figure 14. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Revenue in 2020 Figure 16. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2016-2021) Figure 17. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2022-2027) Figure 18. North America Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Hepatitis C Virus (HCV) Market Share by Type (2016-2027) Figure 20. North America Hepatitis C Virus (HCV) Market Share by Application (2016-2027) Figure 21. North America Hepatitis C Virus (HCV) Market Share by Country (2016-2027) Figure 22. United States Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Hepatitis C Virus (HCV) Market Share by Type (2016-2027) Figure 26. Europe Hepatitis C Virus (HCV) Market Share by Application (2016-2027) Figure 27. Europe Hepatitis C Virus (HCV) Market Share by Country (2016-2027) Figure 28. Germany Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Hepatitis C Virus (HCV) Market Share by Type (2016-2027) Figure 36. Asia-Pacific Hepatitis C Virus (HCV) Market Share by Application (2016-2027) Figure 37. Asia-Pacific Hepatitis C Virus (HCV) Market Share by Region (2016-2027) Figure 38. China Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Hepatitis C Virus (HCV) Market Share by Type (2016-2027) Figure 46. Latin America Hepatitis C Virus (HCV) Market Share by Application (2016-2027) Figure 47. Latin America Hepatitis C Virus (HCV) Market Share by Country (2016-2027) Figure 48. Mexico Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Hepatitis C Virus (HCV) Market Share by Type (2016-2027) Figure 52. Middle East & Africa Hepatitis C Virus (HCV) Market Share by Application (2016-2027) Figure 53. Middle East & Africa Hepatitis C Virus (HCV) Market Share by Country (2016-2027) Figure 54. Turkey Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Hepatitis C Virus (HCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Merck Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 58. Genentech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 59. Vertex Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 60. Janssen and Medivir Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 62. Bristol Myers Squibb Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 63. AbbVie Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 64. Gilead Sciences Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Merck Genentech Vertex Janssen and Medivir F. Hoffmann-La Roche Bristol Myers Squibb AbbVie Gilead Sciences